Supporting Information
收藏Mendeley Data2024-03-27 更新2024-06-27 收录
下载链接：
https://data.mendeley.com/datasets/jk9d6zhrtr
下载链接
链接失效反馈官方服务：
资源简介：
Table S1. Patient-reported side effects Table S2. Baseline and follow-up scores in our daily practice cohort, limited daily practice literature and clinical trials (dupilumab (Q2W) treatment) Figure S1. Estimated mean change in Dermatology Life Quality Index (DLQI) scores in patients with atopic dermatitis from start until 16 weeks of dupilumab treatment (n=95) Figure S2. Investigator Global Assessment (IGA) scores at baseline and follow-up ( between 12 and 16 weeks) Appendix 1 - Criteria for dupilumab treatment set forth by the Dutch Society of Dermatology (NVDV) Appendix 2 – Histograms, Akaike Information Criterion (AIC) of original and sqrt-transformed scale
创建时间：
2024-01-23
